| 23/06/23 | 11:48:01 | 23 Jun 2023 | | Form 8.5 (EPT/RI) |
| 22/06/23 | 08:45:00 | 22 Jun 2023 | | Form 8.5 (EPT/RI) |
| 21/06/23 | 09:38:28 | 21 Jun 2023 | | Form 8.5 (EPT/RI) |
| 20/06/23 | 12:49:06 | 20 Jun 2023 | | Form 8.5 - Allergy Therapeutics plc |
| 20/06/23 | 09:05:07 | 20 Jun 2023 | | Form 8.5 (EPT/RI) |
| 19/06/23 | 07:30:01 | 19 Jun 2023 | | Restoration - Allergy Therapeutics PLC |
| 19/06/23 | 07:01:02 | 19 Jun 2023 | | Interim Results and Lifting Suspension in Trading |
| 19/06/23 | 07:00:04 | 19 Jun 2023 | | Publication of Annual Report and Accounts 2022 |
| 09/06/23 | 07:00:06 | 9 Jun 2023 | | Allergy Therapeutics shares key findings at EAACI |
| 03/05/23 | 09:09:16 | 3 May 2023 | | Form 8.3 - Allergy Therapeutics plc |
| 27/04/23 | 14:15:06 | 27 Apr 2023 | | Result of General Meeting |
| 24/04/23 | 07:00:07 | 24 Apr 2023 | | Southern Fox: Form 8.3 – Allergy Therapeutics Plc |
| 21/04/23 | 07:00:01 | 21 Apr 2023 | | FORM 8 (OPD) – Allergy Therapeutics plc |
| 20/04/23 | 17:29:19 | 20 Apr 2023 | | Project Zebra Rule 2.9 Announcement |
| 19/04/23 | 07:00:04 | 19 Apr 2023 | | Skin-prick testing completes in PROTECT Trial |
| 17/04/23 | 14:30:01 | 17 Apr 2023 | | Form 8 OPD SkyGem Acquisition Limited Replacement |
| 17/04/23 | 10:30:01 | 17 Apr 2023 | | Form 8 (OPD) SkyGem Acquisition Limited |
| 06/04/23 | 14:01:01 | 6 Apr 2023 | | £40.75 million Facility with Equity Financing |
| 06/04/23 | 14:01:01 | 6 Apr 2023 | | Statement Regarding Possible Mandatory Cash Offer |
| 06/04/23 | 14:00:01 | 6 Apr 2023 | | Trading and Business Update |
| 29/03/23 | 07:00:06 | 29 Mar 2023 | | Publication of Interim Results Delayed |
| 27/03/23 | 07:00:03 | 27 Mar 2023 | | Patients dosed in VLP Peanut PROTECT trial |
| 08/03/23 | 17:28:26 | 8 Mar 2023 | | Block Listing Interim Review |
| 03/03/23 | 07:00:06 | 3 Mar 2023 | | PDMR Dealing |
| 07/02/23 | 18:29:07 | 7 Feb 2023 | | Result of AGM |
| 20/01/23 | 07:00:03 | 20 Jan 2023 | | Half-Year Trading Update 2023 |
| 13/01/23 | 17:27:02 | 13 Jan 2023 | | NOTICE OF 2022 ANNUAL GENERAL MEETING |
| 03/01/23 | 07:30:05 | 3 Jan 2023 | | Suspension - Allergy Therapeutics plc |
| 29/12/22 | 11:05:31 | 29 Dec 2022 | | Second Price Monitoring Extn |
| 29/12/22 | 11:00:14 | 29 Dec 2022 | | Price Monitoring Extension |
| 29/12/22 | 09:05:24 | 29 Dec 2022 | | Second Price Monitoring Extn |
| 29/12/22 | 09:00:10 | 29 Dec 2022 | | Price Monitoring Extension |
| 29/12/22 | 07:00:06 | 29 Dec 2022 | | Annual Report and Accounts Delayed |
| 28/12/22 | 07:00:08 | 28 Dec 2022 | | Director Resignation |
| 08/12/22 | 07:00:04 | 8 Dec 2022 | | Key updates on Grass MATA MPL and VLP Peanut |
| 06/12/22 | 07:00:09 | 6 Dec 2022 | | Appointment of Non-Executive Directors |
| 21/11/22 | 07:00:08 | 21 Nov 2022 | | Appointment of Interim CFO |
| 28/10/22 | 07:00:06 | 28 Oct 2022 | | Allergy to resume UK manufacturing production |
| 19/10/22 | 15:39:23 | 19 Oct 2022 | | Holding(s) in Company |
| 17/10/22 | 13:27:34 | 17 Oct 2022 | | Allergy Therapeutics – Result of GM |
| 04/10/22 | 07:00:05 | 4 Oct 2022 | | UK manufacturing update |
| 29/09/22 | 12:00:02 | 29 Sept 2022 | | Allergy Therapeutics at Investor Meet Company |
| 29/09/22 | 07:00:18 | 29 Sept 2022 | | Subscription and Debt Financing |
| 29/09/22 | 07:00:12 | 29 Sept 2022 | | Unaudited Preliminary Results 2022 |
| 05/09/22 | 07:00:11 | 5 Sept 2022 | | Allergy Therapeutics at H.C. Wainwright Conference |
| 02/09/22 | 16:50:44 | 2 Sept 2022 | | Total Voting Rights |
| 02/08/22 | 12:58:33 | 2 Aug 2022 | | Block Listing Interim Review |
| 15/07/22 | 07:00:05 | 15 Jul 2022 | | Trading Update and Notice of Results |
| 01/07/22 | 07:00:11 | 1 Jul 2022 | | Allergy Therapeutics at EAACI Congress 2022 |
| 26/05/22 | 07:00:07 | 26 May 2022 | | Nick Wykeman to step down as CFO |
